1. Physiological parameters in animals and humans;Davies;Pharm. Res,1993
2. Scientific opinion on flavouring group evaluation 312 (FGE.312): 3-[(4-amino-2,2-dioxido-1H-2,1,3-benzothiadiazin-5-yl)oxy]-2,2-dimethyl-N-propylpropanamide;EFSA CEF Panel;EFSA J.,2013
3. Chapter IV.C.9.b. Guidelines for developmental toxicity studies;FDA,2001
4. Good Laboratory Practice for Nonclinical Laboratory Studies;FDA,2014
5. Chapter IV.C.3.a. Short-term toxicity studies with rodents;FDA,2003